CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2022; 57(05): 726-733
DOI: 10.1055/s-0041-1735546
Artigo Original
Infectologia

Pre-operative Colonization by Staphylococcus aureus and Cephalosporin Non-susceptible Bacteria in Patients with Proximal Femoral Fractures[*]

Article in several languages: português | English
1   Seção de Ortopedia e Traumatologia, Hospital Geral de Fortaleza/Exército Brasileiro, Fortaleza, CE, Brasil
2   Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, RJ, Brasil
,
2   Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, RJ, Brasil
,
2   Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, RJ, Brasil
,
2   Departamento de Microbiologia, Imunologia e Parasitologia, Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, RJ, Brasil
3   Laboratórios de Bacteriologia e Micobactérias, Hospital Universitário Pedro Ernesto, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brasil
› Author Affiliations
Sources of Funding The present work was funded by the Instituto Nacional de Pesquisa em Resistência Antimicrobiana - Brazil (INPRA, in the Portuguese acronym), CNPq 465718/2014-0, FAPERGS 17/2551-0000514-7. The present study was also partially supported by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES, in the Portuguese acronym), Finance Code 001.

Abstract

Objective To estimate the frequency of Staphylococcus aureus and cephalosporin nonsusceptible bacteria colonization in patients with proximal femoral fracture during preoperative hospitalization.

Methods Prevalence and incidence assessment in 63 hospitalized patients over 1 year. The median time of pretreatment hospitalization was 12 days. Samples were collected from the nostrils, groin skin and anal mucosa during the pretreatment hospitalization and were tested by the disc-diffusion technique.

Results The hospital colonization incidence and the prevalence of positive results were 14.3 and 44.4% for S. aureus; 3.2 and 6.4% for meticillin-resistant S. aureus; 28.6 and 85.7% for meticillin-resistant coagulase-negative Staphylococcus; 28.6 and 61.9% for cefazolin nonsusceptible Enterobacteriaceae (KFNSE); and 20.6 and 28.6% for cefuroxime nonsusceptible Enterobacteriaceae (CXNSE). In addition, factors such as to the duration of the pretreatment hospitalization period, being non-walker before fracture, antimicrobial use, American Society of Anesthesiologists (ASA) 4 surgical risk, and previous hospitalization, were related to an increase in the incidence of hospital acquisition and prevalence of colonization by the evaluated strains. The prevalence of colonization by KFNSE was three times higher than by CXNSE on admission, and twice as high at the time of fracture treatment.

Conclusion There was a high incidence of hospital colonization and prevalence of colonization by all strains studied, which may guide the indication of prophylactic measures for infection.

* Work developed at the Microbiology, Immunology and Parasitology of the School of Medical Sciences of the Universidade do Estado do Rio de Janeiro, Rio de Janeiro, RJ, Brazil, and of the Hospital Geral de Fortaleza/Exército Brasileiro, Fortaleza, Ceará, Brazil




Publication History

Received: 10 December 2020

Accepted: 07 April 2021

Article published online:
05 January 2022

© 2022. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • Referências

  • 1 Humphreys H, Becker K, Dohmen PM. et al. Staphylococcus aureus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect 2016; 94 (03) 295-304
  • 2 Public Health England. Surveillance of Surgical Site Infections in NHS hospitals in England 2013/14. London Public Heal Engl; 2014 . Available from: http://www.hpa.org.uk/Publications/InfectiousDiseases/SurgicalSiteInfectionReports/1311SSIreport2012to2013data/
  • 3 Hetem DJ, Bootsma MC, Bonten MJ. Prevention of Surgical Site Infections: Decontamination With Mupirocin Based on Preoperative Screening for Staphylococcus aureus Carriers or Universal Decontamination?. Clin Infect Dis 2016; 62 (05) 631-636
  • 4 Gillespie WJ, Walenkamp GH. Antibiotic prophylaxis for surgery for proximal femoral and other closed long bone fractures. Cochrane Database Syst Rev 2010; 2010 (03) CD000244
  • 5 Bassetti M, Righi E, Astilean A. et al. Antimicrobial prophylaxis in minor and major surgery. Minerva Anestesiol 2015; 81 (01) 76-91
  • 6 Schweizer M, Perencevich E, McDanel J. et al. Effectiveness of a bundled intervention of decolonization and prophylaxis to decrease Gram positive surgical site infections after cardiac or orthopedic surgery: systematic review and meta-analysis. BMJ 2013; 346: f2743
  • 7 Deurenberg RH, Stobberingh EE. The evolution of Staphylococcus aureus. Infect Genet Evol 2008; 8 (06) 747-763
  • 8 Torbert JT, Joshi M, Moraff A. et al. Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fractures. J Orthop Trauma 2015; 29 (01) 7-17
  • 9 Logan LK, Weinstein RA. The epidemiology of Carbapenem-resistant enterobacteriaceae: The impact and evolution of a global menace. J Infect Dis 2017; 215 (suppl_ (Suppl. 01) S28-S36
  • 10 Marcel JP, Alfa M, Baquero F. et al. Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect 2008; 14 (10) 895-907
  • 11 Patel JB, Cockerill FR, Bradford PA. et al. M02–A12 Performance Standards for Antimicrobial Disk Susceptibility Tests. Wayne, PA: Clinical and Laboratory Standards Institute; 2015
  • 12 Boye K, Bartels MD, Andersen IS, Møller JA, Westh H. A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V. Clin Microbiol Infect 2007; 13 (07) 725-727
  • 13 Al-Talib H, Yean CY, Al-Khateeb A. et al. A pentaplex PCR assay for the rapid detection of methicillin-resistant Staphylococcus aureus and Panton-Valentine Leucocidin. BMC Microbiol 2009; 9 (01) 113
  • 14 Duran N, Temiz M, Duran GG, Eryılmaz N, Jenedi K. Relationship between the resistance genes to quaternary ammonium compounds and antibiotic resistance in staphylococci isolated from surgical site infections. Med Sci Monit 2014; 20: 544-550
  • 15 Torres K, Sampathkumar P. Predictors of methicillin-resistant Staphylococcus aureus colonization at hospital admission. Am J Infect Control 2013; 41 (11) 1043-1047
  • 16 Kuehnert MJ, Kruszon-Moran D, Hill HA. et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193 (02) 172-179
  • 17 Cho SY, Chung DR. Infection Prevention Strategy in Hospitals in the Era of Community-Associated Methicillin-Resistant Staphylococcus aureus in the Asia-Pacific Region: A Review. Clin Infect Dis 2017; 64 (suppl_ (Suppl. 02) S82-S90
  • 18 Otto M. Community-associated MRSA: what makes them special?. Int J Med Microbiol 2013; 303 (6-7): 324-330
  • 19 Johannessen M, Sollid JE, Hanssen AM. Host- and microbe determinants that may influence the success of S. aureus colonization. Front Cell Infect Microbiol 2012; 2: 56
  • 20 McCarthy H, Rudkin JK, Black NS, Gallagher L, O'Neill E, O'Gara JP. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol 2015; 5: 1-9
  • 21 Hurdle JG, O'Neill AJ, Mody L, Chopra I, Bradley SF. In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxis. J Antimicrob Chemother 2005; 56 (06) 1166-1168
  • 22 Blomfeldt R, Kasina P, Ottosson C, Enocson A, Lapidus LJ. Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. Int Orthop 2015; 39 (11) 2091-2096
  • 23 Ravi S, Zhu M, Luey C, Young SW. Antibiotic resistance in early periprosthetic joint infection. ANZ J Surg 2016; 86 (12) 1014-1018
  • 24 Courtney PM, Melnic CM, Zimmer Z, Anari J, Lee GC. Addition of Vancomycin to Cefazolin Prophylaxis Is Associated With Acute Kidney Injury After Primary Joint Arthroplasty. Clin Orthop Relat Res 2015; 473 (07) 2197-2203
  • 25 Zahar J-R, Lesprit P. Management of multidrug resistant bacterial endemic. Med Mal Infect 2014; 44 (09) 405-411
  • 26 Gallardo-Calero I, Larrainzar-Coghen T, Rodriguez-Pardo D. et al. Increased infection risk after hip hemiarthroplasty in institutionalized patients with proximal femur fracture. Injury 2016; 47 (04) 872-876
  • 27 Marchenay P, Blasco G, Navellou JC. et al. Acquisition of carbapenem-resistant Gram-negative bacilli in intensive care unit: predictors and molecular epidemiology. Med Mal Infect 2015; 45 (1-2): 34-40
  • 28 Armand-Lefèvre L, Angebault C, Barbier F. et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 2013; 57 (03) 1488-1495
  • 29 Khanna S, Pardi DS. Clinical implications of antibiotic impact on gastrointestinal microbiota and Clostridium difficile infection. Expert Rev Gastroenterol Hepatol 2016; 10 (10) 1145-1152